Professor Ke Cheng, the lead researcher, highlighted, "In this new study, we show that inhaled exosomes can efficiently reach the lung and deliver an anti-lung cancer cargo, IL-12 mRNA.
near-term milestones and research funding – is focusing on the development of protein replacement and mRNA therapies that will be delivered using the Oxford University spin-out’s exosome ...